Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cellsSally K. Martin(Centre for Cancer Biology), Andrew C.W. Zannettino(University of South Australia)HaematologicaDecember 16, 200910.3324/haematol.2009.015628Cited by 94SaveCiteExport RISWatch citationsRelated PapersSubclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability|Leukemia|2018|148